Liang Zhao

Scientific Considerations to Move Towards Biowaiver for BCS Class III Drugs: How Modeling and Simulation Can Help?

A. Rostami-Hodjegan, Rodrigo Cristofoletti, Fang Wu, 2021 .

Method to Assess Interactivity of Drugs with Nonparallel Concentration‐Effect Relationships

J. Au, M. Wientjes, Liang Zhao, 2017, Current cancer drug targets.

A new stochastic approach to multi-compartment pharmacokinetic models: probability of traveling route and distribution of residence time in linear and nonlinear systems

Harry Yang, Liang Zhao, Na Li, 2011, Journal of Pharmacokinetics and Pharmacodynamics.

Evaluation of Combination Chemotherapy

J. Au, M. Wientjes, Jessie L-S Au, 2004, Clinical Cancer Research.

Comparison of methods for evaluating drug-drug interaction.

J. Au, M. Wientjes, Jessie L-S Au, 2010, Frontiers in bioscience.

A Method of Estimating and Comparing Volumes Under Receiver Operating Characteristic (ROC) Surfaces

Harry Yang, Liang Zhao, 2010 .

Nontoxic Suramin as a Chemosensitizer in Patients: Dosing Nomogram Development

M. Grever, G. Otterson, M. Villalona-Calero, 2006, Pharmaceutical Research.

Abstract 3485: Uncertainty envelope to evaluate drug interactivity with statistical analysis

M. Wientjes, J. Au, Liang Zhao, 2015 .